PRESTRELSKI STEVEN

USNatural personOfficer

Insider

PRESTRELSKI STEVEN

USNatural personOfficer

Transactions

Issuers

Buys / Sells

0/12

Last tx

31 Jan 2023

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Xeris Biopharma Holdings, Inc.	719,780	reported	31 Jan 2023	tx 13+845,610−22,456
XERIS PHARMACEUTICALS INC	0	reported	05 Oct 2021	tx 31+218,082−814,872

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
31 Jan 2023	GRANT_AWARD	Xeris Biopharma Holdings, Inc.	150,000	0.00 USD
22 Feb 2022	EXERCISE	Xeris Biopharma Holdings, Inc.	11,228	0.69 USD
22 Feb 2022	SALE	Xeris Biopharma Holdings, Inc.	11,228	2.42 USD
22 Feb 2022	EXERCISE	Xeris Biopharma Holdings, Inc.	11,228	0.00 USD	deriv
03 Jan 2022	GRANT_AWARD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Xeris Biopharma Holdings, Inc.	719,780	reported	31 Jan 2023	tx 13+845,610−22,456
XERIS PHARMACEUTICALS INC	0	reported	05 Oct 2021	tx 31+218,082−814,872

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
31 Jan 2023	GRANT_AWARD	Xeris Biopharma Holdings, Inc.	150,000	0.00 USD
22 Feb 2022	EXERCISE	Xeris Biopharma Holdings, Inc.	11,228	0.69 USD
22 Feb 2022	SALE	Xeris Biopharma Holdings, Inc.	11,228	2.42 USD
22 Feb 2022	EXERCISE	Xeris Biopharma Holdings, Inc.	11,228	0.00 USD	deriv
03 Jan 2022	GRANT_AWARD